Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Risposta virologico-clinica e scelta della terapia C. Mussini.
HCV in 2015: New Medication Approvals and Innovative Studies...Including a One-Shot Cure?
Treatment as prevention wong
Hiv eye update 2013
Lab support in hiv treatment and management
Individual level Early warning indicators for Virological failure (independent of adherence) KZN STUDY –UPDATE South African ART Resistance Cohort Studies.
ART: The New, The Old and The Ugly. Our Current ARVS The Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors (NRTIs/ NtRTIs) The Non-Nucleoside Reverse.
HIV Medicine From Guidelines to Practice Kiat Ruxrungtham Professor of Medicine, Chulalongkorn University; and HIV-NAT, Thai Red Cross AIDS Research Center.
Supported by an unrestricted educational grant from ANTIRETROVIRAL TREATMENT HIGHLIGHTS Summarized by Douglas J. Ward, MD, FACP Dupont Circle Physicians.
Slide 1 of 11 From CB Hicks, MD, at Chicago, IL: May 20, 2013, IAS-USA. IAS–USA Charles B. Hicks, MD Professor of Medicine Duke University Medical Center.
Management of Hepatitis B & HIV Co-infection in the Incarcerated Patient: A Clinical Update Douglas G. Fish, MD Head, Division of HIV Medicine Albany Medical.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER NNRTI Resistance David H. Spach, MD Principal Investigator, NW AETC Professor of Medicine, Division of.
